Pallab K Bhattacharyya1, Robert Fox1, Jian Lin1, Paola Raska1, Ken Sakaie1, and Mark J Lowe1
1Cleveland Clinic Foundation, CLEVELAND, OH, United States
Synopsis
It has been reported that structural and functional
connectivity impairment of motor and cognitive network in multiple sclerosis
(MS), as measured by diffusion tensor imaging (DTI) and functional connectivity
(fcMRI) respectively, stabilize after one year of fingolimod treatment. Structural
and functional connectivity index (SFCI), a combined metric of DTI and fcMRI
has previously been demonstrated as a sensitive imaging-based measure of progression
of MS. Change of (i) motor (ii) cognitive and (iii) pathway combined SFCI were
tracked over 2-year fingolimod therapy of MS. SFCI stabilized after one year,
which shows its effectiveness to measure disease progression following therapy .
INTRODUCTION
It has recently
been reported that structural and functional connectivity impairment of motor and
cognitive networks, as measured by diffusion tensor imaging (DTI) and functional
connectivity (fcMRI) respectively, stabilize after one year of fingolimod
treatment of multiple sclerosis (MS).1 Based
on the prior observation of correlated structural and functional connectivity
measures in MS,2,
3
a combined structural and functional connectivity metric has previously been
demonstrated as a sensitive imaging-based measure of disease progression.4 We have used this
combined metric, structural functional composite index (SFCI) incorporating
structural and functional connectivity along the motor and cognitive pathways,
to follow disease progression during 2-year fingolimod therapy.METHODS
Data
Acquisition: Twenty
five patients with MS (42.0±8.6 y, 10 male) were scanned following an institutional
review board approved protocol at 3T at baseline and 6, 12, 18 and 24 months
after start of fingolimod treatment. The whole body Siemens scanner was
upgraded from Tim Trio to Prisma (Erlangen, Germany) during the study; the
upgrade was associated with a change of receive coil from 12 channel head coil
to 20 channel (16 head + 4 spine) coil. DTI was acquired with high angular
resolution diffusion imaging protocol (2mm isotropic, 71 diffusion-weighting
gradients with b=1000sec/mm2 and 8 b=0 volumes, NEX=4). fcMRI data
were acquired with a 2D GRE echoplanar scan (TR/TE=2800/29 ms, 31 slices, slice
thickness 4mm, no gap, 128×128 matrix, 256mm × 256mm FOV, bandwidth 1954
Hz/pixel, 6/8 partial Fourier, 137 repetitions). Pulse plethysmograph and
respiratory bellow were used to monitor physiologic fluctuations. During fcMRI
scans a bite bar was used to minimize motion and all subjects were instructed
to keep eyes closed.
Data Analysis: DTI and fcMRI data
analyses were performed as in literature.1 Structural and
functional connectivity along transcallosal sensorimotor pathway (SMC) and
right frontoparietal (FP) pathway were measured.
Seed and Target Region Definition: Seed
and target for (i) SMC and (ii) FP were defined by (i) left and right primary
motor cortices (M1) and (ii) right middle frontal gyrus (rMFG) and right
inferior parietal lobule (rIPL) respectively. Seeds and targets were identified
using InstaCorr based method5 as in reference.1
Fiber Tracking: Data analysis consisted
of (i) motion correction,6
(ii) voxel by voxel tensor calculation accounting for noise floor correction,7 (iii) fiber
orientation distribution8 calculation for
probabilistic tractography.2
Functional Connectivity: Data analysis
consisted of (i) calculation of a reference timeseries from the arithmetic mean
of nine pixels centered on the seed voxel, (ii) creation of a whole-brain
correlation map from cross-correlation between the reference timeseries and
linearly detrended timeseries of each voxel, (iii) conversion of the
correlation to Student’s t, (iv) normalization of the Student’s t distribution
to zero mean and unit variation9 to generate a
whole-brain z-scored connectivity map, and (v) calculating the mean correlation
within the seed voxel to get fc.
SFCI:
SFCI was constructed as described in literature,4 by summing
z-scored measures of pathway specific DTI and fcMRI. Transverse diffusivity,
TD, the most relevant DTI metric in MS,10,
11
was used as measure of structural connectivity.
Motor, cognitive and combined SFCI measures:
These were calculated following Eqs. 1 and 2 (ZSMC and ZFP
respectively, Fig. 1). Mean and standard deviations of population/sample fc
and TD (for both SMC and FP) were obtained from 17 healthy control scans at 3T
performed at the same center. A combined
SFCI was finally calculated by combining motor and cognitive SFCI measures
following Eq. 3 (Fig. 1).
Analyses of SFCI
measures across time were done using a fixed effect covariate model in R (3.6.0) was used to
estimate the variables at different time-points after accounting for scanner
upgrade. p < 0.05 was considered
as statistically significant. RESULTS AND DISCUSSION
Representative images of single
subject fcMRI maps fiber tracking images are shown in Fig. 2. The combined
structural and functional connectivity along motor and cognitive pathways, and
a pathway-combined SFCI at baseline, 6, 12, 18 and 24 months of fingolimod
therapy are shown in Figs. 3(a), (b) and (c) respectively. By formulation, lower SFCI implies worsening
of network integrity /disease condition. As can be seen from Fig. 3, SFCI
decreases significantly in the 1st year and then increases,
suggesting improvement in pathway specific and combined network integrity after
1st year of fingolimod therapy. This observation is in agreement
with that reported from fcMRI and DTI measures previously. 1CONCLUSION
Motor and cognitive as well as their combined
structural and functional network integrity in MS improves after 1st
year of treatment with fingolimod. SFCI is a quantitative and sensitive measure
of disease progression in MS in a population with clinical intervention. Acknowledgements
This work was supported by funding from Novartis, National Institutes of Health, National Multiple Sclerosis
Society. We thank Thorsten Feiweier of Siemens Healthineers for developing the
DTI pulse sequence and the monopolar+ functionality that was used in this
study.References
1. Bhattacharyya PK, Lowe MJ, Sakaie KE, Li H, Lin J, Fox RJ. Changes in structural and functional connectivity during two years of fingolimod therapy for multiple sclerosis. Magn Reson Imaging. 2020;74:113-120.
2. Lowe MJ, Beall EB, Sakaie KE, Koenig KA, Stone L, Marrie RA, Phillips MD. Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity. Hum Brain Mapp. 2008;29(7):818-827.
3. Lowe MJ, Koenig KA, Beall EB, Sakaie KA, Stone L, Bermel R, Phillips MD. Anatomic connectivity assessed using pathway radial diffusivity is related to functional connectivity in monosynaptic pathways. Brain Connect. 2014;4(7):558-565.
4. Lowe MJ, Koenig KA, Beall E, Lin J, Sakaie KE, Srone L, Phillips MD. Combined Anatomic and Functional Connectivity Metric for Tracking Disease Progression in MS. Proc. Intl. Soc. Mag. Reson. Med. 2016;24:4053.
5. Cox R, Saad Z. InstaCorr in AFNI and SUMA. Second Biennial International Conference on Resting-State Functional Brain Connectivity. Milwaukee, WI; 2010.
6. Sakaie KE, Lowe MJ. Quantitative assessment of motion correction for high angular resolution diffusion imaging. Magn Reson Imaging. 2010;28(2):290-296.
7. Sakaie K, Lowe M. Retrospective correction of bias in diffusion tensor imaging arising from coil combination mode. Magn Reson Imaging. 2017;37:203-208.
8. Sakaie KE, Lowe MJ. An objective method for regularization of fiber orientation distributions derived from diffusion-weighted MRI. Neuroimage. 2007;34(1):169-176.
9. Lowe MJ, Mock BJ, Sorenson JA. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage. 1998;7(2):119-132.
10. Bhattacharyya PK, Fox R, Li H, Lin J, Sakaie KE, Lowe MJ. Evolution of functional and structural connectivity of motor network during 2 years of fingolimod therapy for multiple sclerosis. Proc. Intl. Soc. Mag. Reson. Med. 2018;26:1982.
11. Lowe MJ, Horenstein C, Hirsch JG, Marrie RA, Stone L, Bhattacharyya PK, Gass A, Phillips MD. Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage. 2006;32(3):1127-1133.